Phenothiazine → 9-[(2,4-Diaminoquinazolin-6-yl)methyl]phenothiazine
반응식
NC1N=C(N)C2C(=NC=C(CN(C3C=CC=CC=3)C3C=CC=CC=3)N=2)N=1.[CH:27]1[C:40]2[NH:39][C:38]3[C:33](=[CH:34][CH:35]=[CH:36][CH:37]=3)[S:32][C:31]=2[CH:30]=[CH:29][CH:28]=1.[H-].[Na+].Br.[NH2:44][C:45]1[N:54]=[C:53]([NH2:55])[C:52]2[C:47](=[CH:48][CH:49]=[C:50]([CH2:56]Br)[CH:51]=2)[N:46]=1>>[NH2:44][C:45]1[N:54]=[C:53]([NH2:55])[C:52]2[C:47](=[CH:48][CH:49]=[C:50]([CH2:56][C:37]3[CH:36]=[CH:35][CH:34]=[C:33]4[C:38]=3[NH:39][C:40]3[CH:27]=[CH:28][CH:29]=[CH:30][C:31]=3[S:32]4)[CH:51]=2)[N:46]=1참가 물질
5
실험 절차
9-[(2,4-Diaminoquinazolin-6-yl)methyl]phenothiazine (Formula I: Ar=2,4-diaminoquinazolin-6-yl; W=CH2; X=N; Z=S; m=n=0) is prepared similarly to N-[(2,4-diaminopteridin-6-yl)methyl]-N,N-diphenylamine as disclosed above by using phenothiazine (159 mg, 0.8 mmol), NaH (50 mg, 2.1 mmol), and 2,4-diamino-6-bromomethylquinazoline hydrobromide (100 mg, 0.3 mmol). The product can be purified by chromatography.